Omrix's P2P Acquisition

Omrix raised a round of funding on November 25, 2008. Investors include Johnson & Johnson.

Omrix is a fully integrated biopharmaceutical company that develops, manufactures and markets protein-based biosurgery and passive immunotherapy products. Omrix's biosurgery product line includes prod…

Articles about Omrix's P2P Acquisition: